KIAA1524: A novel MLL translocation partner in acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.leukres.2010.08.017PMID 20943269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

  2009cited by this paper
• NRIP3: a novel translocation partner of MLL detected in a pediatric acute myeloid leukemia with complex chromosome 11 rearrangements

  2009cited by this paper
• CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells

  2008cited by this paper
• CIP2A inhibits PP2A in human malignancies.

  2007cited by this paper
• Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.

  2005cited by this paper
• c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.

  2005cited by this paper
• Coiled Coil Domains: Stability, Specificity, and Biological Implications

  2004cited by this paper
• Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party

  2002cited by this paper
• Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set

  1999cited by this paper
• Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis.

  1995cited by this paper

• The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias

  2020cites this paper
• The role of CIP2A in cancer: A review and update.

  2017cites this paper
• A Systems Biology Analysis of PP2A Functions in Cancer Cells

  2017cites this paper
• Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Chronic Myeloid Leukaemia

  2015cites this paper
• Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism

  2014cites this paper
• Markers for Diagnosis, Prognosis, and Therapy of Acute Myeloid Leukemia

  2014cites this paper
• Role of CIP2A in the antitumor effect of bortezomib in colon cancer.

  2014cites this paper
• The Basic Biology of PP2A in Hematologic Cells and Malignancies

  2014cites this paper
• Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): An oncoprotein with many hands

  2014cites this paper
• Regulation of PP2A by Sphingolipid Metabolism and Signaling

  2014cites this paper
• Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Protein Is Involved in Centrosome Separation through the Regulation of NIMA (Never In Mitosis Gene A)-related Kinase 2 (NEK2) Protein Activity*

  2013cites this paper
• Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells

  2013influential citation
• The MLL recombinome of acute leukemias in 2013

  2013influential citation
• The molecular heterogenity of MLL-rearranged pediatric AML

  2013cites this paper
• adolescents: recommendations from an international expert panel Diagnosis and management of acute myeloid leukemia in children and

  2013cites this paper
• FuseFISH: robust detection of transcribed gene fusions in single cells.

  2013cites this paper
• MLL Gene Alterations in Acute Myeloid Leukaemia (11q23/MLL+ AML)

  2013cites this paper
• Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution

  2012cites this paper
• Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

  2012cites this paper
• Molecular-Based Classification of Acute Myeloid Leukemia and Its Role in Directing Rational Therapy

  2012cites this paper
• Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells

  2012cites this paper
• CIP2A Is a Predictor of Poor Prognosis in Colon Cancer

  2012cites this paper
• Abl-interactor 2 (ABI2): a novel MLL translocation partner in acute myeloid leukemia.

  2012cites this paper
• IDENTIFICATION AND CHARACTERIZATION OF CIP2A AS A NOVEL ONCOGENIC INHIBITOR OF PP2A

  2012cites this paper
• international study -rearranged AML patients: results of an MLL novo pediatric 11q23/ Prognostic significance of additional cytogenetic aberrations in 733 de

  2011cites this paper
• Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression.

  2011cites this paper
• Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study.

  2011influential citation
• CIP2A expression is elevated in cervical cancer

  2010cites this paper